RocketTickers

Immunomedics Announces FDA Approval of Samsung Biologics as Anti

Long
NASDAQ:IMMU   None
IMMU: Immunomedics
2020-08-17 08:00:10
Immunomedics Announces FDA Approval of Samsung Biologics as Antibody Manufacturer for Trodelvy™
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.